시장보고서
상품코드
2082235

POC 면역측정 분석기 확대 시장 보고서(2026년)

Point Of Care (POC) Immunoassay Analyzer Expansion Global Market Report 2026

발행일: | 리서치사: 구분자 The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

가격
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 4,490 금액 안내 화살표 ₩ 6,736,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 금액 안내 화살표 ₩ 9,737,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 금액 안내 화살표 ₩ 12,738,000
※ 부가세 별도
한글목차
영문목차

POC 면역측정 분석기 확대 시장 규모는 최근 강력하게 확대되고 있습니다. 2025년 49억 달러로 평가되었고, 2026년에는 53억 1,000만 달러로 추정되며, CAGR 8.6%로 성장할 전망입니다. 과거의 이러한 성장은 감염병의 확산, 병원 검사실 인프라 구축의 진전, 신속 진단에 대한 수요 증가, 면역 측정 기술의 도입 확대, 그리고 항체 및 항원 검출법의 개선에 기인한 것으로 보입니다.

POC 면역측정 분석기 확대 시장 규모는 향후 몇 년간 강력한 성장이 전망되고 있습니다. 2030년까지 74억 5,000만 달러에 이를 것으로 예측되며, CAGR은 8.8%를 나타낼 전망입니다. 예측 기간 동안의 이러한 성장은 맞춤형 의료 및 바이오마커 기반 검사의 확대, 분산형 의료 제공으로의 전환 가속화, AI를 활용한 진단 시스템의 도입 확대, 재택치료 모니터링의 성장, 신속 진단 기기에 대한 규제 당국의 승인 증가 등에 기인한 것으로 보입니다. 예측 기간 동안의 주요 동향으로는 분산형 현장 진단(Point-of-Care) 생태계의 확대, 다중 면역 측정 플랫폼의 도입 확대, 휴대용 분석 기기에 무선 연결 기능 통합, 카트리지식 신속 검사 시스템의 성장, 가정용 면역 진단 솔루션에 대한 수요 증가 등을 들 수 있습니다.

감염병 유병률 증가는 향후 POC 면역측정 분석기 확대 시장의 성장을 견인할 것으로 예측됩니다. 감염증이란 세균, 바이러스, 기생충, 진균 등의 병원성 미생물에 의해 유발되며, 개인 간에 직접적 또는 간접적으로 전파되는 질환을 말합니다. 감염병 유병률 증가는 전 세계 인구 밀도의 상승에 의해 촉진되고 있으며, 이는 감염 위험과 질병의 확산을 가속화하고 있습니다. 포인트 오브 케어(POC) 면역 분석기의 보급은 감염증 바이오마커를 신속하고 정확하게 분산형 방식으로 검출할 수 있게 함으로써 감염증 관리를 지원하고, 이를 통해 조기 진단 및 질병 대응 노력을 강화합니다. 예를 들어, 2025년 3월, 영국 정부 보건 기관인 영국 보건안보청(UK Health Security Agency)에 따르면, 잉글랜드의 결핵 환자 수는 2024년에 13% 증가하여 2023년의 4,850건에서 5,480건에 달했습니다. 따라서, 감염증 유병률 증가가 POC 면역측정 분석기 확대 시장의 성장을 주도하고 있습니다.

POC 면역측정 분석기 확대 시장에서 사업을 전개하는 주요 기업들은 응급 현장이나 외딴 지역에서의 신속한 진단, 분산형 의료, 실시간 임상 의사 결정에 대한 수요 증가에 대응하기 위해 면역 분석 기술의 발전 등 혁신적인 솔루션 개발에 주력하고 있습니다. 이러한 첨단 면역 분석 장비는 항원 및 항체 반응을 이용하여 바이오마커를 고감도로 검출하는 소형 진단 플랫폼으로, 신속한 결과 보고, 휴대성, 최소한의 시료 전처리, 그리고 다항목 검사 기능 등의 장점을 갖추고 있습니다. 고도의 인프라와 긴 처리 시간이 필요한 기존의 중앙 집중형 검사실용 분석 장비와 달리, POC 시스템은 보다 신속한 결과와 높은 접근성을 바탕으로 환자 곁에서 검사를 수행할 수 있게 해줍니다. 예를 들어, 2023년 7월, Anbio Biotechnology사는 'AF-100S 형광 면역 분석기'를 출시했습니다. 이 시스템은 전혈, 혈청, 혈장 등의 임상 검체 내 바이오마커를 신속하고 정량적으로 검출하기 위해 개발된 소형 자동 형광 면역 분석기입니다. 형광 기반 검출 기술에 자동 보정 및 통합된 품질 관리 기능을 결합함으로써, 중앙 집중식 검사실 시스템에 필적하는 높은 감도와 정확도를 확보하고 있습니다. 또한, 이 분석기는 사용하기 쉬운 인터페이스를 갖추고 있으며, 몇 분 이내에 검사 결과를 제공하기 때문에 응급실, 진료소 및 분산형 의료 환경에 매우 적합합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향 및 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁 및 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별 및 국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황 및 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹 및 대시보드

제39장 시장에서 주목 받는 스타트업

제40장 주요 인수합병(M&A)

제41장 시장 잠재력이 높은 국가, 부문 및 전략

제42장 부록

AJY

Point-of-care immunoassay analyzer expansion refers to the advancement, manufacturing, and adoption of point-of-care immunoassay analyzers for rapid diagnostic testing near the patient. These analyzers utilize immunoassay methods to identify specific proteins, hormones, antigens, or antibodies in biological samples such as blood, urine, or saliva, delivering quick and reliable results to support clinical decision-making.

The primary product types of point of care immunoassay analyzer expansion include portable analyzers, benchtop analyzers, and microfluidic analyzers. Portable analyzers refer to compact diagnostic devices developed for rapid immunoassay testing at or near the patient location, supporting quick clinical decision-making. These solutions are based on technologies such as chemiluminescence, enzyme-linked immunosorbent assay, and lateral flow assay and they utilize sample types including blood, urine, and saliva. The applications involved are infectious diseases, hormonal testing, autoimmune disorders, cardiac markers, and oncology, while the end-use includes hospitals, diagnostic laboratories, home care settings, and academic research institutions.

Tariffs are influencing the point-of-care (poc) immunoassay analyzer expansion market by increasing the cost of imported diagnostic instruments, reagents, microfluidic cartridges, and semiconductor-based components essential for analyzer production. This is slowing the deployment of portable, benchtop, and microfluidic systems, particularly in import-dependent regions such as Asia-Pacific and Latin America, where healthcare infrastructure expansion depends heavily on international suppliers. Hardware-intensive segments such as fully automated benchtop analyzers and cartridge-based microfluidic systems are most impacted due to complex cross-border supply chains. However, tariffs are also driving localization of manufacturing, strengthening regional supply ecosystems, and encouraging domestic production of diagnostic equipment, ultimately improving long-term supply chain resilience and market stability.

The point of care (POC) immunoassay analyzer expansion market research report is one of a series of new reports from The Business Research Company that provides point of care (POC) immunoassay analyzer expansion market statistics, including point of care (POC) immunoassay analyzer expansion industry global market size, regional shares, competitors with a point of care (POC) immunoassay analyzer expansion market share, detailed point of care (POC) immunoassay analyzer expansion market segments, market trends and opportunities, and any further data you may need to thrive in the point of care (POC) immunoassay analyzer expansion industry. This point of care (POC) immunoassay analyzer expansion market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The point of care (POC) immunoassay analyzer expansion market size has grown strongly in recent years. It will grow from $4.9 billion in 2025 to $5.31 billion in 2026 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to rising prevalence of infectious diseases, growth of hospital laboratory infrastructure, increasing demand for rapid diagnostics, expansion of immunoassay technology adoption, improvements in antibody and antigen detection methods.

The point of care (POC) immunoassay analyzer expansion market size is expected to see strong growth in the next few years. It will grow to $7.45 billion by 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to expansion of personalized medicine and biomarker-based testing, increasing shift toward decentralized healthcare delivery, rising adoption of ai-enabled diagnostic systems, growth in home-based healthcare monitoring, increasing regulatory approvals for rapid diagnostic devices. Major trends in the forecast period include expansion of decentralized point-of-care diagnostic ecosystems, increasing adoption of multiplex immunoassay platforms, integration of wireless connectivity in portable analyzers, growth of cartridge-based rapid testing systems, rising demand for at-home immunodiagnostic solutions.

The increasing prevalence of infectious diseases is expected to propel the growth of the point of care immunoassay analyzer expansion market going forward. Infectious diseases are medical conditions caused by pathogenic microorganisms such as bacteria, viruses, parasites, or fungi that spread directly or indirectly between individuals. The increasing prevalence of infectious diseases is driven by rising global population density, which accelerates transmission risks and the spread of diseases. Point of care (POC) immunoassay analyzer expansion supports the management of infectious diseases by enabling rapid, accurate, and decentralized detection of infectious biomarkers, thereby strengthening early diagnosis and disease control efforts. For instance, in March 2025, according to the UK Health Security Agency, a UK-based government health authority, tuberculosis cases in England increased by 13% in 2024, reaching 5,480 cases compared to 4,850 cases in 2023. Therefore, the increasing prevalence of infectious diseases is driving the growth of the point of care immunoassay analyzer expansion market.

Leading companies operating in the point of care immunoassay analyser expansion market are concentrating on developing innovative solutions, such as advancements in immunoassay technologies, to address the growing demand for rapid diagnostics, decentralized healthcare, and real-time clinical decision-making in emergency and remote settings. These advanced immunoassay analyzers are compact diagnostic platforms that use antigen-antibody reactions to detect biomarkers with high sensitivity, offering capabilities such as rapid turnaround times, portability, minimal sample preparation, and multiplex testing functions; unlike conventional centralized laboratory analyzers that require sophisticated infrastructure and longer processing durations, POC systems facilitate near-patient testing with faster results and greater accessibility. For instance, in July 2023, Anbio Biotechnology launched the AF-100S Fluorescence Immunoassay Analyzer. This system is a compact, automated fluorescent immunoassay analyzer developed for rapid quantitative detection of biomarkers in clinical samples such as whole blood, serum, and plasma. It combines fluorescence-based detection technology with automated calibration and integrated quality control to ensure high sensitivity and accuracy comparable to centralized laboratory systems. Additionally, the analyzer includes a user-friendly interface and delivers test results within minutes, making it highly suitable for emergency departments, clinics, and decentralized healthcare environments.

In August 2024, Roche acquired LumiraDx point-of-care technology assets for an undisclosed amount. Through this acquisition, Roche aims to strengthen its diagnostics portfolio by integrating LumiraDx's innovative point-of-care testing platform, which includes immunoassay-based diagnostic capabilities, and expanding its presence in decentralized healthcare solutions. LumiraDx is a UK-based diagnostics company specializing in rapid point-of-care testing technologies.

Major companies operating in the point of care (poc) immunoassay analyzer expansion market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Abbott Laboratories, Siemens Healthineers AG, Danaher Corporation, Becton, Dickinson and Company (BD), Beckman Coulter, Bruker Corporation, BioRad Laboratories, Qiagen N. V., Diasorin, Lepu Medical Technology, SD Biosensor, Eiken Chemical Co. Ltd., Molbio Diagnostics Pvt. Ltd., Maccura Biotechnology Co. Ltd., QuantuMDx Group Ltd., Ustar Biotechnologies Ltd., Mylab Discovery Solutions Pvt Ltd., Akonni Biosystems Inc., Zeesan Biotech Co. Ltd.

North America was the largest region in the point-of-care immunoassay analyzer expansion market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point of care (POC) immunoassay analyzer expansion market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the point of care (POC) immunoassay analyzer expansion market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The point-of-care immunoassay analyzer expansion market consists of revenues earned by entities by providing services such as analyzer installation, calibration, maintenance, cloud-based data connectivity, software integration, remote monitoring, and consumable supply services. The market value also includes the value of related goods sold by the service provider or included within the service offering. The point-of-care immunoassay analyzer expansion market also includes sales of POC immunoassay analyzers, peripheral devices, biosensors, handheld analyzers, automated test systems, sample preparation devices, and associated accessories. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream healthcare providers, distributors, or retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Point Of Care (POC) Immunoassay Analyzer Expansion Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses point of care (poc) immunoassay analyzer expansion market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for point of care (poc) immunoassay analyzer expansion ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The point of care (poc) immunoassay analyzer expansion market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Portable Analyzers; Benchtop Analyzers; Microfluidic Analyzers
  • 2) By Technology: Chemiluminescence; Enzyme-Linked Immunosorbent Assay; Lateral Flow Assay
  • 3) By Sample Type: Blood; Urine; Saliva
  • 4) By Application: Infectious Diseases; Hormonal Testing; Autoimmune Disorders; Cardiac Markers; Oncology
  • 5) By End User: Hospitals; Diagnostic Laboratories; Home Care Settings; Academic Research Institutions
  • Subsegments:
  • 1) By Portable Analyzers: Handheld Immunoassay Analyzers; Battery Operated Diagnostic Analyzers; Wireless Connected Portable Analyzers; Single Test Portable Analyzers; Multi Test Portable Analyzers
  • 2) By Benchtop Analyzers: Compact Laboratory Benchtop Analyzers; High Throughput Benchtop Analyzers; Fully Automated Benchtop Analyzers; Semi Automated Benchtop Analyzers; Multi Assay Benchtop Systems
  • 3) By Microfluidic Analyzers: Lab On A Chip Analyzers; Cartridge Based Microfluidic Analyzers; Continuous Flow Microfluidic Systems; Droplet Based Microfluidic Analyzers; Integrated Microfluidic Diagnostic Systems
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific; Abbott Laboratories; Siemens Healthineers AG; Danaher Corporation; Becton; Dickinson and Company (BD); Beckman Coulter; Bruker Corporation; BioRad Laboratories; Qiagen N.V.; Diasorin; Lepu Medical Technology; SD Biosensor; Eiken Chemical Co. Ltd.; Molbio Diagnostics Pvt. Ltd.; Maccura Biotechnology Co. Ltd.; QuantuMDx Group Ltd.; Ustar Biotechnologies Ltd.; Mylab Discovery Solutions Pvt Ltd.; Akonni Biosystems Inc.; Zeesan Biotech Co. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Point Of Care (POC) Immunoassay Analyzer Expansion Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Point Of Care (POC) Immunoassay Analyzer Expansion Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Point Of Care (POC) Immunoassay Analyzer Expansion Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Point Of Care (POC) Immunoassay Analyzer Expansion Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
    • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.5 Industry 4.0 & Intelligent Manufacturing
  • 4.2. Major Trends
    • 4.2.1 Expansion Of Decentralized Point-Of-Care Diagnostic Ecosystems
    • 4.2.2 Increasing Adoption Of Multiplex Immunoassay Platforms
    • 4.2.3 Integration Of Wireless Connectivity In Portable Analyzers
    • 4.2.4 Growth Of Cartridge-Based Rapid Testing Systems
    • 4.2.5 Rising Demand For At-Home Immunodiagnostic Solutions

5. Point Of Care (POC) Immunoassay Analyzer Expansion Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Diagnostic Laboratories
  • 5.3 Home Care Settings
  • 5.4 Academic Research Institutions
  • 5.5 Other End Users

6. Point Of Care (POC) Immunoassay Analyzer Expansion Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Point Of Care (POC) Immunoassay Analyzer Expansion Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Point Of Care (POC) Immunoassay Analyzer Expansion PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Point Of Care (POC) Immunoassay Analyzer Expansion Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Point Of Care (POC) Immunoassay Analyzer Expansion Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Point Of Care (POC) Immunoassay Analyzer Expansion Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Point Of Care (POC) Immunoassay Analyzer Expansion Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Point Of Care (POC) Immunoassay Analyzer Expansion Market Segmentation

  • 9.1. Global Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Portable Analyzers, Benchtop Analyzers, Microfluidic Analyzers
  • 9.2. Global Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Chemiluminescence, Enzyme-Linked Immunosorbent Assay, Lateral Flow Assay
  • 9.3. Global Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Blood, Urine, Saliva
  • 9.4. Global Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Infectious Diseases, Hormonal Testing, Autoimmune Disorders, Cardiac Markers, Oncology
  • 9.5. Global Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Diagnostic Laboratories, Home Care Settings, Academic Research Institutions
  • 9.6. Global Point Of Care (POC) Immunoassay Analyzer Expansion Market, Sub-Segmentation Of Portable Analyzers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Handheld Immunoassay Analyzers, Battery Operated Diagnostic Analyzers, Wireless Connected Portable Analyzers, Single Test Portable Analyzers, Multi Test Portable Analyzers
  • 9.7. Global Point Of Care (POC) Immunoassay Analyzer Expansion Market, Sub-Segmentation Of Benchtop Analyzers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Compact Laboratory Benchtop Analyzers, High Throughput Benchtop Analyzers, Fully Automated Benchtop Analyzers, Semi Automated Benchtop Analyzers, Multi Assay Benchtop Systems
  • 9.8. Global Point Of Care (POC) Immunoassay Analyzer Expansion Market, Sub-Segmentation Of Microfluidic Analyzers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Lab On A Chip Analyzers, Cartridge Based Microfluidic Analyzers, Continuous Flow Microfluidic Systems, Droplet Based Microfluidic Analyzers, Integrated Microfluidic Diagnostic Systems

10. Point Of Care (POC) Immunoassay Analyzer Expansion Market Regional And Country Analysis

  • 10.1. Global Point Of Care (POC) Immunoassay Analyzer Expansion Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Point Of Care (POC) Immunoassay Analyzer Expansion Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Point Of Care (POC) Immunoassay Analyzer Expansion Market

  • 11.1. Asia-Pacific Point Of Care (POC) Immunoassay Analyzer Expansion Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Point Of Care (POC) Immunoassay Analyzer Expansion Market

  • 12.1. China Point Of Care (POC) Immunoassay Analyzer Expansion Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Point Of Care (POC) Immunoassay Analyzer Expansion Market

  • 13.1. India Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Point Of Care (POC) Immunoassay Analyzer Expansion Market

  • 14.1. Japan Point Of Care (POC) Immunoassay Analyzer Expansion Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Point Of Care (POC) Immunoassay Analyzer Expansion Market

  • 15.1. Australia Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Point Of Care (POC) Immunoassay Analyzer Expansion Market

  • 16.1. Indonesia Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Point Of Care (POC) Immunoassay Analyzer Expansion Market

  • 17.1. South Korea Point Of Care (POC) Immunoassay Analyzer Expansion Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Point Of Care (POC) Immunoassay Analyzer Expansion Market

  • 18.1. Taiwan Point Of Care (POC) Immunoassay Analyzer Expansion Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Point Of Care (POC) Immunoassay Analyzer Expansion Market

  • 19.1. South East Asia Point Of Care (POC) Immunoassay Analyzer Expansion Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Point Of Care (POC) Immunoassay Analyzer Expansion Market

  • 20.1. Western Europe Point Of Care (POC) Immunoassay Analyzer Expansion Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Point Of Care (POC) Immunoassay Analyzer Expansion Market

  • 21.1. UK Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Point Of Care (POC) Immunoassay Analyzer Expansion Market

  • 22.1. Germany Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Point Of Care (POC) Immunoassay Analyzer Expansion Market

  • 23.1. France Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Point Of Care (POC) Immunoassay Analyzer Expansion Market

  • 24.1. Italy Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Point Of Care (POC) Immunoassay Analyzer Expansion Market

  • 25.1. Spain Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Point Of Care (POC) Immunoassay Analyzer Expansion Market

  • 26.1. Eastern Europe Point Of Care (POC) Immunoassay Analyzer Expansion Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Point Of Care (POC) Immunoassay Analyzer Expansion Market

  • 27.1. Russia Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Point Of Care (POC) Immunoassay Analyzer Expansion Market

  • 28.1. North America Point Of Care (POC) Immunoassay Analyzer Expansion Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Point Of Care (POC) Immunoassay Analyzer Expansion Market

  • 29.1. USA Point Of Care (POC) Immunoassay Analyzer Expansion Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Point Of Care (POC) Immunoassay Analyzer Expansion Market

  • 30.1. Canada Point Of Care (POC) Immunoassay Analyzer Expansion Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Point Of Care (POC) Immunoassay Analyzer Expansion Market

  • 31.1. South America Point Of Care (POC) Immunoassay Analyzer Expansion Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Point Of Care (POC) Immunoassay Analyzer Expansion Market

  • 32.1. Brazil Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Point Of Care (POC) Immunoassay Analyzer Expansion Market

  • 33.1. Middle East Point Of Care (POC) Immunoassay Analyzer Expansion Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Point Of Care (POC) Immunoassay Analyzer Expansion Market

  • 34.1. Africa Point Of Care (POC) Immunoassay Analyzer Expansion Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Point Of Care (POC) Immunoassay Analyzer Expansion Market Regulatory and Investment Landscape

36. Point Of Care (POC) Immunoassay Analyzer Expansion Market Competitive Landscape And Company Profiles

  • 36.1. Point Of Care (POC) Immunoassay Analyzer Expansion Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Point Of Care (POC) Immunoassay Analyzer Expansion Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Point Of Care (POC) Immunoassay Analyzer Expansion Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Point Of Care (POC) Immunoassay Analyzer Expansion Market Other Major And Innovative Companies

  • Becton Dickinson and Company (BD), Beckman Coulter, Bruker Corporation, BioRad Laboratories, Qiagen N.V., Diasorin, Lepu Medical Technology, SD Biosensor, Eiken Chemical Co. Ltd., Molbio Diagnostics Pvt. Ltd., Maccura Biotechnology Co. Ltd., QuantuMDx Group Ltd., Ustar Biotechnologies Ltd., Mylab Discovery Solutions Pvt Ltd., Akonni Biosystems Inc.

38. Global Point Of Care (POC) Immunoassay Analyzer Expansion Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Point Of Care (POC) Immunoassay Analyzer Expansion Market

41. Point Of Care (POC) Immunoassay Analyzer Expansion Market High Potential Countries, Segments and Strategies

  • 41.1 Point Of Care (POC) Immunoassay Analyzer Expansion Market In 2030 - Countries Offering Most New Opportunities
  • 41.2 Point Of Care (POC) Immunoassay Analyzer Expansion Market In 2030 - Segments Offering Most New Opportunities
  • 41.3 Point Of Care (POC) Immunoassay Analyzer Expansion Market In 2030 - Growth Strategies
    • 41.3.1 Market Trend Based Strategies
    • 41.3.2 Competitor Strategies

42. Appendix

  • 42.1. Abbreviations
  • 42.2. Currencies
  • 42.3. Historic And Forecast Inflation Rates
  • 42.4. Research Inquiries
  • 42.5. The Business Research Company
  • 42.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
문의하기